CORPORATE TALK SERIES
(Chief Scientist and Co-Founder, Coherent Knowledge)
Bio: Benjamin Grosof, PhD, is Co-Founder and Chief Scientist at Coherent Knowledge, an AI startup that provides highly explainable decision support via query answering. He has pioneered technology and industry standards for knowledge graphs and expressively flexible semantic rules, their acquisition from natural language, how to combine them with machine learning, and a wide variety of applications including in defense & security, finance, legal & policy, e- commerce & supply chain, health care & life science, and helpdesk. In particular, he has led invention of declarative logic programs that extend databases scalably with powerful implications and meta-logic features such as probabilities, higher-order syntax, bounded rationality (restraint), exceptions/argumentation (defeasibility), and user-friendly explanations. Previously, he was a technical/research executive in AI at: the Allen Institute for AI’s predecessor; Accenture; and Kyndi, a venture-backed AI startup. Earlier, he was a MIT Sloan professor and DARPA PI, and an IBM Research scientist. His background includes a part-time expert consulting practice, Stanford PhD in computer science (specialty AI), Harvard BA in applied mathematics, 60+ refereed publications, 10,000+ citations, 5 patents, 2 W3C standards, and 5 major industry software products.
Title of the Talk: AI’s Secret Weapon for Ubiquitous Computing: Extended Logic Programs
(Principal Scientist, Bristol Myers Squibb)
Bio: Celine Han is a computational biologist and principal scientist in Translational Bioinformatics at Bristol Myers Squibb (BMS). Her focus of research is to advance oncology clinical trial programs and to influence development strategies by applying cutting-edge bioinformatic analyses on clinical trials and real-world data. Her work involves driving complex collaborations and communications with various partners for biomarker discovery and patient stratification. Prior to joining BMS, she finished her postdoctoral training at Harvard Medical School, Dana- Farber Cancer Institute and Broad Institute of MIT and Harvard. She studied the resistance to hormone therapy for patient stratification in metastatic prostate cancer. She completed her Ph.D. training in Bioinformatics and Genomics at Pennsylvania State University studying the epigenetics and transcriptional regulation in erythropoiesis. Outside of research, she is passionate about science communication, mentoring, teaching, and being a lifelong learner.
|Full Paper Submission:||7th November 2021|
|Acceptance Notification:||17th November 2021|
|Final Paper Submission:||24th November 2021|
|Early Bird Registration||21st November 2021|
|Presentation Submission:||23rd November 2021|
|Conference:||1 - 4 December 2021|
• Conference Proceedings will be submitted for publication at IEEE Xplore® digital library.
• Best Paper Award will be given for each track.
• Conference Record No 53757